Second-Quarter Highlights:
-
Sales increase 7% to $23.9 million
-
Net income of $1.2 million
-
Backlog increases 36% from year-end to $16.4 million
-
Company acquires RITEC’s ruggedized printer product line for civil
and commercial aircraft
WEST WARWICK, R.I.--(BUSINESS WIRE)--Aug. 19, 2015--
Astro-Med, Inc. (NASDAQ: ALOT), a leading manufacturer of data
visualization technology for the specialty printing and test and
measurement markets, today reported second-quarter fiscal 2016 sales of
$23.9 million, a 7% increase year-on-year. Second-quarter net income was
$1.2 million, or $0.16 per diluted share.
“Astro-Med posted a profitable second quarter highlighted by continued
top-line growth, strong orders of $25.4 million and a healthy backlog,”
said Gregory A. Woods, the Company’s President and Chief Executive
Officer. “Sales in our domestic channel increased by 14% year-on-year in
the second quarter. International sales were down 8% in the second
quarter compared with the second quarter of fiscal 2015. Current year’s
second-quarter international sales includes an unfavorable foreign
exchange impact of $0.9 million. However, with our recent expansion into
Asia and Latin America, and the broadening of our sales reach in Canada,
we are expanding our market share and competitive positioning for
international growth.”
“The QuickLabel Systems business continues to deliver double-digit
growth in bookings and shipments, as our new color inkjet label printers
and global marketing initiatives drive robust orders for labels, inks
and other consumables,” Woods continued. “Demand is so strong, in fact,
that for the first time in Astro-Med’s history we will soon be expanding
to a third shift at our largest label manufacturing facility in West
Warwick. This step will improve asset utilization and overall labor
efficiency, helping to drive margin enhancement toward the end of this
year.”
“We continue to manage costs carefully and allocate capital prudently,
both in terms of infrastructure and strategic acquisitions, to support
our growing business,” Woods said. “In June, we acquired RITEC Inc.’s
ruggedized printer product line for civil and commercial aircraft. We
expect the RITEC acquisition to further enhance our technology
portfolio, expand our business relationships and enable us to accelerate
the pace of growth in our aerospace markets.”
Gross profit for the second quarter of fiscal 2016 was $9.8 million, or
41.1% of sales, compared with $9.6 million, or 42.9% of sales, for the
year-earlier period.
Net income for the second quarter of fiscal 2016 was $1.2 million, or
$0.16 per diluted share, compared with $1.4 million, or $0.18 per
diluted share, in the same period of fiscal 2015.
Cash and cash equivalents at August 1, 2015 were $18.3 million, compared
with $23.1 million at year-end fiscal 2015. The change in the cash
position reflected the June 2015 product line acquisition from RITEC
Inc. for approximately $7.4 million in cash.
Second-Quarter Business Segment Highlights
QuickLabel Systems
-
Sales of $17.1 million, up 12.1% from $15.3 million for the second
quarter of fiscal 2015
-
Segment operating profit of $2.7 million, or a record 15.9% of sales,
compared with $2.2 million, or 14.7% of sales, for the second quarter
of fiscal 2015
-
New Kiaro! D label printer certified to BS5609 standard for maritime
shipment of chemical goods as required by GHS labeling standards
Test & Measurement
-
Sales of $6.8 million, down 3.8% from the second quarter of fiscal
2015, reflecting a shift in delivery timing requirements for certain
aircraft manufacturers to later in the year for the Company’s
ruggedized printer product line
-
Segment operating profit of $0.9 million, or 13.1% of sales, compared
with $1.4 million, or 19.1% of sales, for the comparable period of
fiscal 2015
-
Broadened product line with launch of new data acquisition system
(Daxus) for distributed networking
-
Received Apple AirPrint Certification for ToughWriter 5
Board of Directors Declares Regular Quarterly Dividend
On August 17, 2015, the Directors of Astro-Med, Inc. declared a regular
quarterly cash dividend of $0.07 per share. The dividend, which
represents a cash dividend of $0.28 per share on an annualized basis, is
payable on October 2, 2015, to shareholders of record as of the close of
business on September 11, 2015.
Business Outlook
“As we move into the second half of fiscal 2016, demand remains strong
and we are optimistic about the outlook for our business,” Woods
concluded. “Orders through the first six months of the fiscal year stand
at a robust $51.5 million, 15.4% ahead of the prior year. The Company is
generating positive cash flow and we are well positioned to achieve our
key operational and financial objectives. Looking ahead, we expect to
continue to strategically grow the business while making investments in
new equipment and related infrastructure that will enable us to further
optimize our processes and strengthen margins.”
Second-Quarter FY 2016 Conference Call
Astro-Med will conduct an investor conference call at 9:00 a.m. EDT
today. Investors can participate in the conference call by dialing
877-876-9177 (U.S. and Canada) or 785-424-1666 (International) with
passcode 136369. Please join the call at least five minutes prior to the
start time. You can also hear a live webcast of the call by accessing
the Investors section of Astro-Med’s website, www.Astro-MedInc.com.
Following the live broadcast, an audio webcast of the call will be
available at www.Astro-MedInc.com.
A telephone replay of the conference call will be available for seven
days by dialing 888-348-4629 (U.S. and Canada) or 719-884-8882
(International) with passcode 136369.
Forward-Looking Statements
Information included in this news release may contain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements are not statements of
historical fact, but rather reflect our current expectations concerning
future events and results. These statements may include the use of the
words “believes,” “expects,” “intends,” “plans,” “anticipates,”
“likely,” “continues,” “may,” “will,” and similar expressions to
identify forward-looking statements. Such forward-looking statements,
including those concerning growth through acquisitions, involve risks,
uncertainties and other factors, some of which are beyond our control,
which may cause our actual results, performance or achievements to be
materially different from those expressed or implied by such
forward-looking statements. These risks, uncertainties, and factors
include, but are not limited to, those factors set forth in the
Company’s Annual Report on Form 10-K for the fiscal year ended January
31, 2015 and subsequent filings Astro-Med makes with the Securities and
Exchange Commission. The Company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a result of
new information, future events or otherwise. The reader is cautioned not
to unduly rely on such forward-looking statements when evaluating the
information presented in this news release.
|
ASTRO-MED, INC. Consolidated Statements of Income In
Thousands, Except per Share Data (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
|
|
|
August 1, 2015
|
|
|
August 2, 2014
|
|
|
August 1, 2015
|
|
|
August 2, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
|
|
$
|
23,938
|
|
|
$
|
22,366
|
|
|
|
$
|
46,144
|
|
|
|
$
|
43,140
|
|
Cost of Sales
|
|
|
|
|
14,092
|
|
|
|
12,777
|
|
|
|
|
27,268
|
|
|
|
|
24,915
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
|
|
9,846
|
|
|
|
9,589
|
|
|
|
|
18,876
|
|
|
|
|
18,225
|
|
|
|
|
|
|
41.1%
|
|
|
|
42.9%
|
|
|
|
|
40.9%
|
|
|
|
|
42.2%
|
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling and Marketing
|
|
|
|
|
4,664
|
|
|
|
4,503
|
|
|
|
|
8,992
|
|
|
|
|
8,878
|
|
Research and Development
|
|
|
|
|
1,565
|
|
|
|
1,479
|
|
|
|
|
3,361
|
|
|
|
|
2,850
|
|
General and Administration
|
|
|
|
|
1,783
|
|
|
|
1,443
|
|
|
|
|
3,241
|
|
|
|
|
2,634
|
|
|
|
|
|
|
8,012
|
|
|
|
7,425
|
|
|
|
|
15,594
|
|
|
|
|
14,362
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income
|
|
|
|
|
1,834
|
|
|
|
2,164
|
|
|
|
|
3,282
|
|
|
|
|
3,863
|
|
|
|
|
|
|
7.7%
|
|
|
|
9.7%
|
|
|
|
|
7.1%
|
|
|
|
|
9.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income (Expense), Net
|
|
|
|
|
21
|
|
|
|
83
|
|
|
|
|
254
|
|
|
|
|
(38)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Before Taxes
|
|
|
|
|
1,855
|
|
|
|
2,247
|
|
|
|
|
3,536
|
|
|
|
|
3,825
|
|
Income Tax Provision
|
|
|
|
|
687
|
|
|
|
812
|
|
|
|
|
1,158
|
|
|
|
|
1,261
|
|
Net Income
|
|
|
|
|
1,168
|
|
|
|
1,435
|
|
|
|
|
2,378
|
|
|
|
|
2,564
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income per Common Share - Basic
|
|
|
|
$
|
0.16
|
|
|
$
|
0.19
|
|
|
|
$
|
0. 33
|
|
|
|
$
|
0.34
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income per Common Share - Diluted
|
|
|
|
$
|
0.16
|
|
|
$
|
0.18
|
|
|
|
$
|
0.32
|
|
|
|
$
|
0.33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Avg Number of Common Shares - Basic
|
|
|
|
|
7,278
|
|
|
|
7,704
|
|
|
|
|
7,269
|
|
|
|
|
7,652
|
|
Weighted Avg Number of Common Shares - Diluted
|
|
|
|
|
7,469
|
|
|
|
7,916
|
|
|
|
|
7,459
|
|
|
|
|
7,883
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends Declared per Common Share
|
|
|
|
$
|
0.07
|
|
|
$
|
0.07
|
|
|
|
$
|
0.14
|
|
|
|
$
|
0.14
|
|
|
ASTRO-MED, INC.
|
Selected Balance Sheet Data
|
In Thousands
|
|
|
|
|
(Unaudited)
|
|
|
(Audited)
|
|
|
|
As of
|
|
|
As of
|
|
|
|
August 1, 2015
|
|
|
January 31, 2015
|
Cash & Marketable Securities
|
|
|
$18,329
|
|
|
$23,132
|
Current Assets
|
|
|
$55,513
|
|
|
$61,918
|
Total Assets
|
|
|
$75,396
|
|
|
$74,330
|
Current Liabilities
|
|
|
$8,873
|
|
|
$9,569
|
Shareholders’ Equity
|
|
|
$65,379
|
|
|
$63,511
|

View source version on businesswire.com: http://www.businesswire.com/news/home/20150819005558/en/
Source: Astro-Med, Inc.
Astro-Med, Inc.
Joseph P. O’Connell, 800-343-4039
Senior Vice
President and Chief Financial Officer
or
Sharon Merrill
Associates, Inc.
David Calusdian, 617-542-5300
Executive Vice
President & Partner
ALOT@investorrelations.com